Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorouracil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 2109 for your search:
Start Over
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 85
Sponsor: Other
Protocol IDs: COLOGEN, NCT00138060
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000574159, CHUL-BIO-COLON, INCA-RECF0356, RECF0356, NCT00559676
Combination Chemotherapy in Treating Older Patients With Solid Tumour,
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and over
Sponsor: Other
Protocol IDs: CDR0000593133, GERCOR-OLD, EudraCT-2007004103-36, GERCOR-OLD07-SA07-1, NCT00664911
Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 21
Sponsor: Other
Protocol IDs: PK01/16/08, NCT00808184
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
Phase: Phase IV
Type: Prevention
Status: Closed
Age: No age specified
Sponsor: Other
Protocol IDs: 562, NCT00847912
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-13, NCT00911092
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CPT_08_001, NCT01271582
FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DERMATUX, NCT01315990
Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: HDE-ALL-2011, NCT01457040
A Translational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ASCENT)
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25753, NCT01588990
A Study of Avastin (Bevacizumab) in Combination With 5-FU Based Doublet Chemotherapy in Patients With Colorectal Cancer And Previously Untreated Unresectable Liver-Only Metastases
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML28419, NCT01695772
Phase II/III Randomized Study of CDDP/5-FU vs CDDP/5-FU/IFN-A for Metastatic Pancreatic Cancer (Summary Last Modified 02/95)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-40924
Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3278
Phase II/III Randomized Study of Fluorouracil/Leucovorin with vs without Oxaliplatin for Inoperable Metastatic Colorectal Cancer (Summary Last Modified 03/98)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: FRE-DEB95-OXA-01, EU-96023
Phase II/III Randomized Study of Interleukin-2 and Interferon alfa With Versus Without Fluorouracil for Metastatic Renal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor:
Protocol IDs: FRE-FNCLCC-95009, EU-96026
Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-784651
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
Phase II-III HMM vs FAC (5-FU/ADR/CTX) Chemotherapy for Advanced Transitional Cell Bladder Cancer with Impaired Renal Function
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7904
Control Arm of a Comparison of Various Phase II Agents vs 5-FU for Disseminated or Recurrent Colorectal Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7940
Comparison of Sequential Chemotherapy with Cyclophosphamide plus 5-Fluorouracil vs 5-Fluorouracil Alone for Metastatic Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WCG-124
Master Protocol to Compare MTX/5-FU vs CACP/5-FU vs Phase II Agent for Squamous Cell Cancer of the Head and Neck (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8223/24/25, SWOG-8224, SWOG-8225
Phase II/III Chemotherapy with CTX/ADR/5-FU/MTX with and without Cell Synchronization with Tamoxifen and Premarin for Metastatic Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: NCI-76-C-377A, NCI-MB-160A
Phase II/III Chemotherapy with CTX/ADR/MTX/5-FU, with vs without Hormonal Synchronization with TMX/Premarin, for Metastatic Mammary Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-76-C-377B, NCI-MB-160B
Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1281
Start Over